|
Volumn 39, Issue 3, 1999, Pages 154-160
|
Atypical neuroleptics
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMISULPRIDE;
CHLORPROMAZINE;
CLOZAPINE;
DOPAMINE 2 RECEPTOR;
NEUROLEPTIC AGENT;
OLANZAPINE;
PROLACTIN;
QUETIAPINE;
RISPERIDONE;
SERTINDOLE;
AGRANULOCYTOSIS;
COST EFFECTIVENESS ANALYSIS;
DROWSINESS;
DRUG COST;
DRUG ELIMINATION;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HYPERPROLACTINEMIA;
HYPERSALIVATION;
LIVER TOXICITY;
NEUROLEPTIC MALIGNANT SYNDROME;
NEUTROPENIA;
NONHUMAN;
OBESITY;
RECEPTOR BLOCKING;
REVIEW;
SCHIZOPHRENIA;
SINUS TACHYCARDIA;
SUICIDAL BEHAVIOR;
TARDIVE DYSKINESIA;
|
EID: 0032837510
PISSN: 00327611
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (19)
|